Diagnostic Imaging Market: Steady Growth Projected with a 5.8% CAGR Outlook 2030

According to the report published by Allied Market Research, the global medical/diagnostic imaging market garnered $38.5 billion in 2020, and is expected to reach $68.8 billion by 2030, witnessing a CAGR of 5.8% from 2021 to 2030.

Sample Report-

https://www.alliedmarketresearch.com/request-sample/1400

Increasing Prevalence of Chronic Diseases: The global burden of chronic diseases like cancer, cardiovascular disorders, and neurological conditions has been rising steadily. Diagnostic imaging plays a crucial role in the early detection, staging, and treatment monitoring of these diseases.

Growing Geriatric Population: With an aging population, there has been a surge in age-related diseases and conditions. As a result, the demand for diagnostic imaging services has increased significantly to cater to the elderly population's healthcare needs.

Rising Awareness and Demand for Early Diagnosis: There is an increasing emphasis on preventive healthcare and early disease detection. Diagnostic imaging modalities enable healthcare professionals to detect diseases at their early stages, leading to better treatment outcomes and improved patient survival rates.

Market Segmentation:

Imaging Modality:

X-ray Imaging: This includes traditional X-ray systems and digital radiography (DR) systems, which are widely used for various applications such as bone imaging, chest imaging, and dental radiography.
Computed Tomography (CT): CT scanners provide detailed cross-sectional images and are commonly used in oncology, cardiology, and neurology.
Magnetic Resonance Imaging (MRI): MRI machines offer detailed images of soft tissues and are commonly used in neurology, musculoskeletal, and abdominal imaging.
Ultrasound: Ultrasound systems use high-frequency sound waves to create real-time images, commonly used in obstetrics, gynecology, and abdominal imaging.
Nuclear Medicine: This includes Single-Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) systems, used in oncology and cardiology for functional imaging.
Others: This may include emerging modalities or hybrid imaging systems, such as PET/CT or MRI/PET.

Application:

Oncology: Diagnostic imaging is extensively used for cancer detection, staging, and treatment monitoring.
Cardiology: Imaging modalities are used to assess heart function, detect cardiovascular diseases, and plan interventions.
Neurology: Neuroimaging is vital for diagnosing and monitoring neurological disorders like stroke, Alzheimer's disease, and multiple sclerosis.
Orthopedics: Diagnostic imaging helps in evaluating bone fractures, joint disorders, and musculoskeletal conditions.
Gynecology: Ultrasound and other imaging techniques are utilized for imaging the female reproductive system.
Gastrointestinal Imaging: Imaging aids in diagnosing and monitoring gastrointestinal disorders.
Other Applications: This may include imaging for urology, pulmonary diseases, and various other medical specialties.

End-User:

Hospitals: Hospitals are the major consumers of diagnostic imaging services and equipment due to their comprehensive healthcare facilities.
Diagnostic Imaging Centers: Standalone imaging centers that offer various imaging services to patients and referring physicians.
Ambulatory Surgical Centers (ASCs): These facilities provide outpatient surgeries and diagnostic services, including imaging.
Clinics and Physician Offices: Smaller healthcare facilities that offer diagnostic imaging services in-house or through partnerships with imaging centers.
Others: Research institutions, academic medical centers, and veterinary clinics may also be included in this category.

Region:

North America: Including the United States and Canada.
Europe: Encompassing countries within the European continent.
Asia-Pacific: Including countries such as China, Japan, India, and Australia.
Latin America: Encompassing countries in Central and South America.
Middle East and Africa: Including countries from the Middle East and African regions.

Competitive Landscape:

Leading players of the global medical/diagnostic imaging market analyzed in the research include Canon Inc. (Canon Medical Systems USA, Inc.), Esaote SpA, Carestream Health, Inc., Hitachi Ltd. (Hitachi Healthcare America Corporation), General Electric Company (GE Healthcare), Koninklijke Philips N.V., Hologic, Inc., Planmeca OY, Materialise NV, and Siemens AG.

Trending Reports in Healthcare Industry:

Orthopedic 3D Printing Devices Market https://www.alliedmarketresearch.com/orthopedic-3d-printing-devices-market-A111259

Radiopharmaceuticals Market https://www.alliedmarketresearch.com/radiopharmaceuticals-market-A14458

Patient Simulator Market https://www.alliedmarketresearch.com/patient-simulator-market-A11667

Breast Cancer Drugs Market https://www.alliedmarketresearch.com/breast-cancer-drugs-market-A11123

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

This release was published on openPR.